All Stories

  1. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma

    Article • Blood Coagulation & Fibrinolysis, June 2015, Wolters Kluwer Health

    Dr Pernille Just Vinholt

  2. Hypokalemia in Acute Medical Patients: Risk Factors and Prognosis

    Article • The American Journal of Medicine, January 2015, Elsevier

    Dr Pernille Just Vinholt, Mikkel Brabrand

  3. CYP2C19*17increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel

    Article • Clinical and Experimental Pharmacology and Physiology, November 2014, Wiley

    Dr Pernille Just Vinholt, Kim Brosen

  4. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients

    Article • European Journal Of Haematology, March 2014, Wiley

    Dr Pernille Just Vinholt

  5. Characteristics of patients with community-acquired bacteremia who have low levels of C-reactive protein (≤20 mg/L)

    Article • Journal of Infection, February 2014, Elsevier

    Dr Pernille Just Vinholt

  6. An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma

    Article • Thrombosis Research, May 2013, Elsevier

    Dr Niels Peter Rønnow Sand, Dr Pernille Just Vinholt

  7. Protein S and protein C measurements should not be undertaken during vitamin K antagonist therapy

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2013, De Gruyter

    Dr Pernille Just Vinholt

  8. Does C-reactive protein independently predict mortality in adult community-acquired bacteremia patients with known sepsis severity?

    Article • Apmis, December 2012, Wiley

    Dr Pernille Just Vinholt

  9. The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease

    Article • Thrombosis and Haemostasis, July 2005, Schattauer GmbH

    Dr Pernille Just Vinholt

  10. Existence of a Clinically Relevant Interaction between Clopidogrel and HMG-CoA Reductase Inhibitors? Re-evaluating the Evidence

    Article • Basic & Clinical Pharmacology & Toxicology, February 2005, Wiley

    Dr Pernille Just Vinholt